Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05766748 |
| Title | Study of Effect of Azeliragon in Patients Refractory to First-Line Metastatic Pancreatic Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Cantex Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute | RECRUITING | Los Angeles | California | 90048 | United States | Details |
| Boca Raton Regional Hospital, Lynn Cancer Institute | RECRUITING | Boca Raton | Florida | 33486 | United States | Details |
| Williamette Valley Cancer Institute and Research Center | RECRUITING | Eugene | Oregon | 97401 | United States | Details |
| AHN Cancer Institute - Allegheny General Hospital | RECRUITING | Pittsburgh | Pennsylvania | 15212 | United States | Details |
| Prisma Health - Upstate | RECRUITING | Greenville | South Carolina | 29605 | United States | Details |
| Texas Oncology - Northeast Texas | RECRUITING | Tyler | Texas | 75702 | United States | Details |